Pharmacogenetics of psychotropic drugs:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cambridge, UK
Cambridge University Press
2002
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index Part I : Introduction -- - Genes and psychopharmacology: exploring the interface - Bernard Lerer -- - Part II : Clinical background and research design -- - From pharmacogenetics to pharmacogenomics of psychotropic drug response - Anil K. Malhotra -- - Neuropsychopharmacology: the interface between genes and psychiatric nosology - Thomas A. Ban -- - Methodological issues in psychopharmacogenetics - Sheldon H. Preskorn -- - Statistical approaches in psychopharmacogenetics - Fabio Macciardi -- - Part III : Molecular background -- - Psychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways - K. Peter Lesch, Jens Benninghoff, Angelika Schmitt -- - RNA processing regulation and interindividual variation - Colleen M. Niswender, Linda K. Hutchinson -- - Part IV : Pharmacokinetics -- - Pharmacogenetics of psychotropic drug metabolism - Vural Ozdemir [and others] -- - Pharmacogenetics of chiral psychotropic drugs - Pierre Baumann, Chin B. Eap -- - Part V : Specific psychotropic drugs and disorders -- - Clozapine response and genetic variation in neurotransmitter receptor targets - David A. Collier [and others] -- - Genetic factors underlying drug-induced tardive dyskinesia - Ronnen H. Segman, Bernard Lerer -- - Functional gene-linked polymorphic regions in pharmacogenetics - Marco Catalano -- - Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders - Emanuela Mundo, James L. Kennedy -- - Pharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex - Smita A. Pandit [and others] -- - Genetic factors and long-term prophylaxis in bipolar disorder - Martin Alda -- - Genetic influences on responsiveness to anticonvulsant drugs - Thomas N. Ferraro -- - Apolipoprotein E as a marker in the treatment of Alzheimer's disease - Keith Schappert, Pierre Sevigny, Judes Poirier -- - Genetic variation and drug dependence risk factors - Joel Gelernter, Henry Kranzler -- - Part IV : Pharmacogenetics and brain imaging -- - Brain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia - Steven G. Potkin, James L. Kennedy, Vincenzo S. Basile -- - Part VII : Industry perspectives -- - Pharmacogenetics in psychotropic drug discovery and development - William Z. Potter, AnnCatherine Van Lone, Larry Altstiel -- - High-throughput single nucleotide polymorphism genotyping - Anne Shalom, Ariel Darvasi Provides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the findings that have already emerged. Coverage extends to antipsychotics, antidepressants, mood stabilizing, cognitive-enhancing and anxiolytic drugs. An essential reference for all clinicians and researchers working in this field |
| Beschreibung: | 1 Online-Ressource (x, 446 pages) |
| ISBN: | 051104173X 0511044100 0511119712 9780511041730 9780511044106 9780511119712 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043145744 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 051104173X |c electronic bk. |9 0-511-04173-X | ||
| 020 | |a 0511044100 |9 0-511-04410-0 | ||
| 020 | |a 0511119712 |c electronic bk. |9 0-511-11971-2 | ||
| 020 | |a 9780511041730 |c electronic bk. |9 978-0-511-04173-0 | ||
| 020 | |a 9780511044106 |9 978-0-511-04410-6 | ||
| 020 | |a 9780511119712 |c electronic bk. |9 978-0-511-11971-2 | ||
| 035 | |a (OCoLC)70731046 | ||
| 035 | |a (DE-599)BVBBV043145744 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 615/.788 |2 21 | |
| 084 | |a XI 5800 |0 (DE-625)153018:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Pharmacogenetics of psychotropic drugs |c edited by Bernard Lerer |
| 264 | 1 | |a Cambridge, UK |b Cambridge University Press |c 2002 | |
| 300 | |a 1 Online-Ressource (x, 446 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Part I : Introduction -- - Genes and psychopharmacology: exploring the interface - Bernard Lerer -- - Part II : Clinical background and research design -- - From pharmacogenetics to pharmacogenomics of psychotropic drug response - Anil K. Malhotra -- - Neuropsychopharmacology: the interface between genes and psychiatric nosology - Thomas A. Ban -- - Methodological issues in psychopharmacogenetics - Sheldon H. Preskorn -- - Statistical approaches in psychopharmacogenetics - Fabio Macciardi -- - Part III : Molecular background -- - Psychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways - K. Peter Lesch, Jens Benninghoff, Angelika Schmitt -- - RNA processing regulation and interindividual variation - Colleen M. Niswender, Linda K. Hutchinson -- - Part IV : Pharmacokinetics -- - Pharmacogenetics of psychotropic drug metabolism - Vural Ozdemir [and others] -- - Pharmacogenetics of chiral psychotropic drugs - Pierre Baumann, Chin B. Eap -- | ||
| 500 | |a - Part V : Specific psychotropic drugs and disorders -- - Clozapine response and genetic variation in neurotransmitter receptor targets - David A. Collier [and others] -- - Genetic factors underlying drug-induced tardive dyskinesia - Ronnen H. Segman, Bernard Lerer -- - Functional gene-linked polymorphic regions in pharmacogenetics - Marco Catalano -- - Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders - Emanuela Mundo, James L. Kennedy -- - Pharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex - Smita A. Pandit [and others] -- - Genetic factors and long-term prophylaxis in bipolar disorder - Martin Alda -- - Genetic influences on responsiveness to anticonvulsant drugs - Thomas N. Ferraro -- - Apolipoprotein E as a marker in the treatment of Alzheimer's disease - Keith Schappert, Pierre Sevigny, Judes Poirier -- - Genetic variation and drug dependence risk factors - Joel Gelernter, Henry Kranzler -- | ||
| 500 | |a - Part IV : Pharmacogenetics and brain imaging -- - Brain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia - Steven G. Potkin, James L. Kennedy, Vincenzo S. Basile -- - Part VII : Industry perspectives -- - Pharmacogenetics in psychotropic drug discovery and development - William Z. Potter, AnnCatherine Van Lone, Larry Altstiel -- - High-throughput single nucleotide polymorphism genotyping - Anne Shalom, Ariel Darvasi | ||
| 500 | |a Provides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the findings that have already emerged. Coverage extends to antipsychotics, antidepressants, mood stabilizing, cognitive-enhancing and anxiolytic drugs. An essential reference for all clinicians and researchers working in this field | ||
| 650 | 7 | |a MEDICAL / Pain Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Psychiatry / Psychopharmacology |2 bisacsh | |
| 650 | 7 | |a Pharmacogenetics |2 fast | |
| 650 | 7 | |a Psychotropic drugs |2 fast | |
| 650 | 4 | |a Pharmacogenetics | |
| 650 | 4 | |a Psychotropic Drugs | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Psychotropic drugs | |
| 650 | 4 | |a Pharmacogenetics | |
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 0 | 1 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Lerer, Bernard |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-521-80617-8 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-521-80617-6 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028569935 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175599813525504 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043145744 |
| classification_rvk | XI 5800 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)70731046 (DE-599)BVBBV043145744 |
| dewey-full | 615/.788 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.788 |
| dewey-search | 615/.788 |
| dewey-sort | 3615 3788 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05376nmm a2200649zc 4500</leader><controlfield tag="001">BV043145744</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">051104173X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-511-04173-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0511044100</subfield><subfield code="9">0-511-04410-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0511119712</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-511-11971-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511041730</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-511-04173-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511044106</subfield><subfield code="9">978-0-511-04410-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511119712</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-511-11971-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)70731046</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043145744</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.788</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5800</subfield><subfield code="0">(DE-625)153018:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacogenetics of psychotropic drugs</subfield><subfield code="c">edited by Bernard Lerer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, UK</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 446 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Part I : Introduction -- - Genes and psychopharmacology: exploring the interface - Bernard Lerer -- - Part II : Clinical background and research design -- - From pharmacogenetics to pharmacogenomics of psychotropic drug response - Anil K. Malhotra -- - Neuropsychopharmacology: the interface between genes and psychiatric nosology - Thomas A. Ban -- - Methodological issues in psychopharmacogenetics - Sheldon H. Preskorn -- - Statistical approaches in psychopharmacogenetics - Fabio Macciardi -- - Part III : Molecular background -- - Psychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways - K. Peter Lesch, Jens Benninghoff, Angelika Schmitt -- - RNA processing regulation and interindividual variation - Colleen M. Niswender, Linda K. Hutchinson -- - Part IV : Pharmacokinetics -- - Pharmacogenetics of psychotropic drug metabolism - Vural Ozdemir [and others] -- - Pharmacogenetics of chiral psychotropic drugs - Pierre Baumann, Chin B. Eap --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Part V : Specific psychotropic drugs and disorders -- - Clozapine response and genetic variation in neurotransmitter receptor targets - David A. Collier [and others] -- - Genetic factors underlying drug-induced tardive dyskinesia - Ronnen H. Segman, Bernard Lerer -- - Functional gene-linked polymorphic regions in pharmacogenetics - Marco Catalano -- - Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders - Emanuela Mundo, James L. Kennedy -- - Pharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex - Smita A. Pandit [and others] -- - Genetic factors and long-term prophylaxis in bipolar disorder - Martin Alda -- - Genetic influences on responsiveness to anticonvulsant drugs - Thomas N. Ferraro -- - Apolipoprotein E as a marker in the treatment of Alzheimer's disease - Keith Schappert, Pierre Sevigny, Judes Poirier -- - Genetic variation and drug dependence risk factors - Joel Gelernter, Henry Kranzler --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Part IV : Pharmacogenetics and brain imaging -- - Brain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia - Steven G. Potkin, James L. Kennedy, Vincenzo S. Basile -- - Part VII : Industry perspectives -- - Pharmacogenetics in psychotropic drug discovery and development - William Z. Potter, AnnCatherine Van Lone, Larry Altstiel -- - High-throughput single nucleotide polymorphism genotyping - Anne Shalom, Ariel Darvasi</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Provides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the findings that have already emerged. Coverage extends to antipsychotics, antidepressants, mood stabilizing, cognitive-enhancing and anxiolytic drugs. An essential reference for all clinicians and researchers working in this field</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pain Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Psychiatry / Psychopharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacogenetics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lerer, Bernard</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-521-80617-8</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-521-80617-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028569935</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043145744 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:18:51Z |
| institution | BVB |
| isbn | 051104173X 0511044100 0511119712 9780511041730 9780511044106 9780511119712 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028569935 |
| oclc_num | 70731046 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (x, 446 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Pharmacogenetics of psychotropic drugs edited by Bernard Lerer Cambridge, UK Cambridge University Press 2002 1 Online-Ressource (x, 446 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Part I : Introduction -- - Genes and psychopharmacology: exploring the interface - Bernard Lerer -- - Part II : Clinical background and research design -- - From pharmacogenetics to pharmacogenomics of psychotropic drug response - Anil K. Malhotra -- - Neuropsychopharmacology: the interface between genes and psychiatric nosology - Thomas A. Ban -- - Methodological issues in psychopharmacogenetics - Sheldon H. Preskorn -- - Statistical approaches in psychopharmacogenetics - Fabio Macciardi -- - Part III : Molecular background -- - Psychopharmacogenetic-neurodevelopmental interface in serotonergic gene pathways - K. Peter Lesch, Jens Benninghoff, Angelika Schmitt -- - RNA processing regulation and interindividual variation - Colleen M. Niswender, Linda K. Hutchinson -- - Part IV : Pharmacokinetics -- - Pharmacogenetics of psychotropic drug metabolism - Vural Ozdemir [and others] -- - Pharmacogenetics of chiral psychotropic drugs - Pierre Baumann, Chin B. Eap -- - Part V : Specific psychotropic drugs and disorders -- - Clozapine response and genetic variation in neurotransmitter receptor targets - David A. Collier [and others] -- - Genetic factors underlying drug-induced tardive dyskinesia - Ronnen H. Segman, Bernard Lerer -- - Functional gene-linked polymorphic regions in pharmacogenetics - Marco Catalano -- - Alternative phenotypes and the pharmacogenetics of mood and anxiety disorders - Emanuela Mundo, James L. Kennedy -- - Pharmacogenetics of anxiolytic drugs and the GABA-benzodiazepine receptor complex - Smita A. Pandit [and others] -- - Genetic factors and long-term prophylaxis in bipolar disorder - Martin Alda -- - Genetic influences on responsiveness to anticonvulsant drugs - Thomas N. Ferraro -- - Apolipoprotein E as a marker in the treatment of Alzheimer's disease - Keith Schappert, Pierre Sevigny, Judes Poirier -- - Genetic variation and drug dependence risk factors - Joel Gelernter, Henry Kranzler -- - Part IV : Pharmacogenetics and brain imaging -- - Brain imaging and pharmacogenetics in Alzheimer's disease and schizophrenia - Steven G. Potkin, James L. Kennedy, Vincenzo S. Basile -- - Part VII : Industry perspectives -- - Pharmacogenetics in psychotropic drug discovery and development - William Z. Potter, AnnCatherine Van Lone, Larry Altstiel -- - High-throughput single nucleotide polymorphism genotyping - Anne Shalom, Ariel Darvasi Provides a conceptual framework for understanding and studying the pharmacogenetics of psychotropic drugs, reviews advances in the field, and describes the findings that have already emerged. Coverage extends to antipsychotics, antidepressants, mood stabilizing, cognitive-enhancing and anxiolytic drugs. An essential reference for all clinicians and researchers working in this field MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Pharmacogenetics fast Psychotropic drugs fast Pharmacogenetics Psychotropic Drugs Medizin Psychotropic drugs Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 s Pharmakogenetik (DE-588)4271255-5 s 1\p DE-604 Lerer, Bernard Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-521-80617-8 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-521-80617-6 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Pharmacogenetics of psychotropic drugs MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Pharmacogenetics fast Psychotropic drugs fast Pharmacogenetics Psychotropic Drugs Medizin Psychotropic drugs Pharmakogenetik (DE-588)4271255-5 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| subject_GND | (DE-588)4271255-5 (DE-588)4047729-0 |
| title | Pharmacogenetics of psychotropic drugs |
| title_auth | Pharmacogenetics of psychotropic drugs |
| title_exact_search | Pharmacogenetics of psychotropic drugs |
| title_full | Pharmacogenetics of psychotropic drugs edited by Bernard Lerer |
| title_fullStr | Pharmacogenetics of psychotropic drugs edited by Bernard Lerer |
| title_full_unstemmed | Pharmacogenetics of psychotropic drugs edited by Bernard Lerer |
| title_short | Pharmacogenetics of psychotropic drugs |
| title_sort | pharmacogenetics of psychotropic drugs |
| topic | MEDICAL / Pain Medicine bisacsh MEDICAL / Psychiatry / Psychopharmacology bisacsh Pharmacogenetics fast Psychotropic drugs fast Pharmacogenetics Psychotropic Drugs Medizin Psychotropic drugs Pharmakogenetik (DE-588)4271255-5 gnd Psychopharmakon (DE-588)4047729-0 gnd |
| topic_facet | MEDICAL / Pain Medicine MEDICAL / Psychiatry / Psychopharmacology Pharmacogenetics Psychotropic drugs Psychotropic Drugs Medizin Pharmakogenetik Psychopharmakon |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=112592 |
| work_keys_str_mv | AT lererbernard pharmacogeneticsofpsychotropicdrugs |